Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide

被引:1
|
作者
Watanabe, H
Takehana, K
Date, M
Shinozaki, T
Raz, A
机构
[1] WAYNE STATE UNIV, SCH MED, BARBARA ANN KARMANOS CANC INST, DETROIT, MI 48201 USA
[2] GUNMA UNIV, SCH MED, DEPT ORTHOPED SURG, MAEBASHI, GUMMA 371, JAPAN
[3] AJINOMOTO CO INC, CENT RES LABS, KAWASAKI KU, KAWASAKI, KANAGAWA 210, JAPAN
[4] WAYNE STATE UNIV, SCH MED, DEPT PATHOL, DETROIT, MI 48201 USA
[5] WAYNE STATE UNIV, SCH MED, DEPT RADIAT ONCOL, DETROIT, MI 48201 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To date, the structure of the autocrine motility factor (AMF), a tumor-secreted cytokine which stimulates cell migration in vitro and metastasis in vivo, is unknown. Here, AMF secreted by Gc-4 PF murine fibrosarcoma into a protein-free conditioned media was isolated, purified, and microsequenced, The results demonstrate that AMF is the previously cloned cytokine and enzyme designated as neuroleukin, and phosphohexose isomerase (PHI), which has been independently implicated in cell motility, and to be a cancer progression marker. PHI catalyzes isomerization of glucose 6-phosphate to fructose 6-phosphate and is specific for both sugars. Murine AMF exhibits the enzymatic properties of PHI and rabbit heart PHI-stimulated mouse fibrosarcoma cells' motility similar to those of the endogenous AMF. Specific PHI inhibitors (carbohydrate phosphates) inhibited enzymatic activity and AMF-induced cell motility.
引用
收藏
页码:2960 / 2963
页数:4
相关论文
共 50 条
  • [21] The role of autocrine motility factor in tumor and tumor microenvironment
    Funasaka, Tatsuyoshi
    Raz, Avraham
    CANCER AND METASTASIS REVIEWS, 2007, 26 (3-4) : 725 - 735
  • [22] The role of autocrine motility factor in tumor and tumor microenvironment
    Tatsuyoshi Funasaka
    Avraham Raz
    Cancer and Metastasis Reviews, 2007, 26 : 725 - 735
  • [23] PURIFICATION AND CHARACTERIZATION OF PHOSPHOHEXOSE ISOMERASE FROM HUMAN GASTROINTESTINAL CARCINOMA AND ITS POTENTIAL RELATIONSHIP TO NEUROLEUKIN
    BAUMANN, M
    BRAND, K
    CANCER RESEARCH, 1988, 48 (24) : 7018 - 7021
  • [24] MORE ON PHOSPHOHEXOSE ISOMERASE AS A TUMOR-MARKER
    DERIL, GVM
    PAVESI, F
    LOTZNIKER, M
    MORATTI, R
    CLINICAL CHEMISTRY, 1986, 32 (06) : 1242 - 1243
  • [25] Regulation of autocrine motility factor receptor expression in tumor cell locomotion and metastasis
    Silletti, S
    Raz, A
    ATTEMPTS TO UNDERSTAND METASTASIS FORMATION II: REGULATORY FACTORS, 1996, 213 : 137 - 169
  • [26] Raft-Dependent Endocytosis of Autocrine Motility Factor/Phosphoglucose Isomerase: A Potential Drug Delivery Route for Tumor Cells
    Kojic, Liliana D.
    Wiseman, Sam M.
    Ghaidi, Fariba
    Joshi, Bharat
    Nedev, Hinyu
    Saragovi, H. Uri
    Nabi, Ivan R.
    PLOS ONE, 2008, 3 (10):
  • [27] Silencing of phosphoglucose isomerase/autocrine motility factor decreases U87 human glioblastoma cell migration
    Li, Yang
    Wei, Zhenqing
    Dong, Bin
    Lian, Zhigang
    Xu, Yinghui
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 37 (04) : 998 - 1004
  • [28] Phosphoglucose Isomerase/Autocrine Motility Factor Promotes Melanoma Cell Migration through ERK Activation Dependent on Autocrine Production of Interleukin-8
    Araki, Kenichiro
    Shimura, Tatsuo
    Yajima, Toshiki
    Tsutsumi, Soichi
    Suzuki, Hideki
    Okada, Kohji
    Kobayashi, Tsutomu
    Raz, Avraham
    Kuwano, Hiroyuki
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (47) : 32305 - 32311
  • [29] PURIFICATION AND CHARACTERIZATION OF TUMOR-DERIVED MAST-CELL MOTILITY FACTOR THAT POSSESSES AUTOCRINE MOTILITY ACTIVITY
    YANO, H
    ZETTER, B
    MOLECULAR BIOLOGY OF THE CELL, 1992, 3 : A360 - A360
  • [30] Autocrine motility factor/phosphoglucose isomerase regulates ER stress and cell death through control of ER calcium release
    M Fu
    L Li
    T Albrecht
    J D Johnson
    L D Kojic
    I R Nabi
    Cell Death & Differentiation, 2011, 18 : 1057 - 1070